Agf Investments LLC Repligen Corp Transaction History

Agf Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $519,836 - $692,457	-3,134 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $216,083 - $271,059	-1,198 Reduced 27.65%	3,134 $609,000
Q4 2020 Feb 08, 2021	SELL	$148.08 - $206.57 $744,398 - $1.04 Million	-5,027 Reduced 53.71%	4,332 $830,000
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $13,353 - $17,251	-109 Reduced 1.15%	9,359 $1.38 Million
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $884,532 - $1.32 Million	9,377 Added 10304.4%	9,468 $1.17 Million
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $7,731 - $9,931	91 New	91 $9,000

495

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.